RediClinic announces availability of flu vaccines
HOUSTON RediClinic on Wednesday announced that flu vaccinations for the 2007-2008 flu season are now available at all of its in-store clinics.
RediClinic is offering the vaccination for either $25 or free when other select RediClinic “Stay Well” health services are purchased.
RediClinic “Stay Well” health packages are geared to help consumers and their family members of all ages stay healthy throughout the cold and flu season. The select packages, which are all priced at $69 and include the flu vaccination for free ($25 savings), are:
Pneumonia vaccination—the Center for Disease Control and Prevention recommends this vaccination for anyone over the age of 65 or anyone over age 2 with long-term chronic health issues
Tdap vaccination (tetanus, diphtheria and pertussis/whooping cough)—the CDC recommends this vaccination for everyone who has not had a tetanus or diptheria shot, or a Tdap booster, in the past two years
“7 Vital Tests for Health”—includes cholesterol screening, glucose screening, kidney and liver function tests, thyroid panel, complete blood count, blood pressure and body mass index
As an additional offer, RediClinic is including a free flu shot with a $69 physical exam.
In a report just released, the CDC reiterated a previous recommendation that everyone should be vaccinated, including school-aged children, in order to reduce the risk of becoming ill with influenza or of transmitting it to others. The CDC report also reemphasized the importance of administering two doses of flu vaccine to all children, ages six months to eight years, if they have not been vaccinated previously.
“The flu vaccine is the single most effective way to avoid getting the flu, and we are pleased to be able to provide our customers with a convenient and affordable way to get vaccinated,” stated Web Golinkin, president and chief executive officer of RediClinic.
Mylan announces new appointments
PITTSBURGH Upon the news of the acquisition involving Merck’s KGaA generic business by Mylan, Mylan released a group of statements regarding new appointments to positions within the company worldwide.
The appointments include: Harry Korman as President, North America; Rajiv Malik as Executive Vice President in charge or Global Technical Operations; Carolyn Myers, Ph.D. President-elect of Dey; Christy Taylor as Chief Operating Officer of Dey; Didier Barret as President of Europe, Middle East, and Africa; Heather Bresch as Chief Operating Officer; and John Montgomery as President, Asia Pacific.
Mylan acquired Merck’s generics for $6.8 billion in cash.
FDA approves Afluria flu vaccine
AUSTRALIA The Food and Drug Administration has approved CSL’s flu vaccine Afluria, according to The Australian.
The company expects to ship two million doses as part of its first shipment to the U.S. between mid-December and early February. The company expects to increase its export to 20 million doses over the next four years.
“We’ve entered the US market quite late, but over the next few years we hope to increase our export of flu vaccine to the US to 20 million doses,” CSL’s Dr Rachel David said.